Skip to main content

Advertisement

SpringerLink
Log in

Prevalence, viral load, and physical status of HPV 16 and 18 in cervical adenosquamous carcinoma

  • Original Article
  • Published:
Virchows Archiv Aims and scope Submit manuscript

Abstract

Adenosquamous carcinoma of the uterine cervix is a rare mixture of malignant squamous and glandular epithelial elements and accounts for approximately 10% of cervical carcinomas. The aims of the present study were to evaluate the prevalence, physical status, and viral load of HPV 16 and 18 in adenosquamous carcinoma. Formalin-fixed paraffin-embedded tissue samples from 20 cases of histologically diagnosed adenosquamous carcinoma were examined. The squamous and glandular components were separately microdissected and analyzed for their HPV DNA subtype, viral load, and physical status using real-time polymerase chain reaction (PCR). The percentages of HPV 16- and 18-positive cases among all the HPV-positive cases were 36.8% (7/19) and 57.9% (11/19) in the squamous epithelial elements and 33.3% (6/18) and 61.1% (11/18) in the glandular elements, respectively. PCR analysis with E2 primers revealed that seven of eleven (63.6%) HPV 18-positive cases had the pure integrated form in both elements. The mean HPV 16 DNA copy numbers/cell was 7.22 in the squamous elements and 1.33 in the glandular elements (p = 0.04) while the corresponding mean HPV 18 DNA copy numbers/cell was 1.50 and 0.89, respectively. The prevalence of HPV 18 in adenosquamous carcinoma was high and many HPV 18-positive cases were the pure integrated form resulting in very low copy numbers/cell. It is possible that more aggressive transformation with early integration of HPV 18 results in cases with greater chromosomal instabilities, higher growth rates, and rapid progression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Parazzini F, La Vecchia C (1999) Epidemiology of adenocarcinoma of the cervix. Gynecol Oncol 39:40–46

    Article  Google Scholar 

  2. Warton V (1995) Neoplasms of the cervix. In: Holland JF, Frei E III, Bast RC Jr et al (eds) Cancer medicine, Vol. II, 4th edn. Williams & Wilkins, Toronto, pp 2227–2261

    Google Scholar 

  3. Ferguson AW, Svobada-Newman SM, Frank TS (1998) Analysis of human papillomavirus infection and molecular alterations in adenocarcinoma of the cervix. Mod Pathol 11:11–18

    PubMed  CAS  Google Scholar 

  4. Lombard I, Vincent-Salman A, Validire P et al (1998) Human papillomavirus genotype as a major determinant of the course of cervical cancer. J Clin Oncol 16:2613–2619

    PubMed  CAS  Google Scholar 

  5. Anciaux D, Lawrence WD, Gregoire L (1997) Glandular lesions of the uterine cervix: prognostic implications of human papillomavirus status. Int J Gynecol Obstet 16:103–110

    CAS  Google Scholar 

  6. Parker MF, Arroyo GF, Geradts J et al (1997) Molecular characterization of adenocarcinoma of the cervix. Gynecol Path 64:242–251

    Article  CAS  Google Scholar 

  7. Uchiyama M, Iwasaki T, Matsuo N et al (1997) Correlation between human papillomavirus positivity and p53 gene overexpression in adenocarcinoma of the uterine cervix. Gynecol Oncol 65:23–29

    Article  PubMed  CAS  Google Scholar 

  8. Duggan MA, McGregor SE, Benoit JL et al (1995) The human papillomavirus status of invasive cervical adenocarcinoma: a clinicopathological and outcome analysis. Hum Pathol 26:319–325

    Article  PubMed  CAS  Google Scholar 

  9. Tenti P, Romagnoli S, Silini E et al (1996) Human papillomavirus types 16 and 18 infection in infiltrating adenocarcinoma of the cervix: PCR analysis of 138 cases and correlation with histologic type and grade. Am J Clin Pathol 106:52–56

    PubMed  CAS  Google Scholar 

  10. Gordon AN, Bornstein J, Kaufman RH et al (1989) Human papillomavirus associated with adenocarcinoma and adenosquamous carcinoma of the cervix: analysis by in situ hybridization. Gynecol Oncol 35:345–348

    Article  PubMed  CAS  Google Scholar 

  11. Yamakawa Y, Forslund O, Teshima H et al (1994) Human papillomavirus DNA in adenocarcinoma and adenosquamous carcinoma of the uterine cervix detected by polymerase chain reaction (PCR). Gynecol Oncol 53:190–195

    Article  PubMed  CAS  Google Scholar 

  12. Tase T, Okagaki T, Clark BA et al (1988) Human papillomavirus types and localization in adenocarcinoma and adenosquamous carcinoma of the uterine cervix: a study by in situ DNA hybridization. Cancer Res 48:993–998

    PubMed  CAS  Google Scholar 

  13. Teshima H, Beaudenon S, Koi K et al (1997) Human papillomavirus type 18 DNA sequences in adenocarcinoma and adenosquamous carcinoma of the uterine cervix. Arch Gynecol Obstet 259:169–177

    Article  PubMed  CAS  Google Scholar 

  14. Adcock LL, Julian TM, Okazaki T et al (1982) Carcinoma of the uterine cervix FIGO Stage I-B. Gynecol Oncol 14:199–208

    Article  PubMed  CAS  Google Scholar 

  15. Yajima A, Fukuda M, Noda K (1984) Histopathological findings concerning the morphogenesis of mixed carcinoma of the uterine cervix. Gynecol Oncol 18:157–164

    Article  PubMed  CAS  Google Scholar 

  16. Corden SA, Sant-Cassia LJ, Easton AJ et al (1999) The integration of HPV-18 DNA in cervical carcinoma. J Clin Pathol: Mol Pathol 52:275–282

    Article  CAS  Google Scholar 

  17. Wells M, Nesland JM, Ostor AG et al (2003) Epithelial tumors. In: Tavassoli FA, Devilee P (eds) World Health Organization classification of tumors. Pathology and genetics of tumors of the breast and female genital organs. IARC Press, Lyon, pp 262–279

    Google Scholar 

  18. Fujinaga Y, Shimada M, Okazawa K et al (1991) Simultaneous detection and typing of genital human papillomavirus DNA using the polymerase chain reaction. J Gen Virol 72:1039–1044

    Article  PubMed  CAS  Google Scholar 

  19. Fujii T, Masumoto N, Saito M et al (2005) Comparison between in situ hybridization and real-time PCR technique as a means of detecting the integrated form of human papillomavirus 16 in cervical neoplasia. Diagn Mol Pathol 14(2):103–108

    Article  PubMed  CAS  Google Scholar 

  20. Ho CM, Chien TY, Huang SH et al (2006) Integrated human papillomavirus types 52 and 58 are infrequently found in cervical cancer, and high viral loads predict risk of cervical cancer. Gynecol Oncol 102:54–60

    Article  PubMed  Google Scholar 

  21. Moberg M, Gustavsson I, Gyllensten U (2003) Real-time PCR-based system for simultaneous quantification of human papillomavirus types associated with high risk of cervical cancer. J Clin Microbiol 41:3221–3228

    Article  PubMed  CAS  Google Scholar 

  22. Yoshida T, Sano T, Kanuma T et al (2008) Quantitative real-time polymerase chain reaction analysis of the type distribution, viral load, and physical status of human papillomavirus in liquid-based cytology samples from cervical lesions. Int J Gynecol Cancer 18:121–127

    Article  PubMed  CAS  Google Scholar 

  23. Ito T, Ishizuka T, Suzuki K et al (2000) Cervical cancer in young Japanese women. Arch Gynecol Obstet 264:68–70

    Article  PubMed  CAS  Google Scholar 

  24. Clark MA, Naahas W, Marker RJ et al (1991) Cervical cancer: women aged 35 and younger compared with women aged 36 and older. Am J Clin Oncol 14:352–356

    Article  PubMed  CAS  Google Scholar 

  25. Elliot PM, Tattersall MHN, Coppleson M et al (1989) Changing character of cervical cancer in young women. BMJ 298:288–290

    Article  Google Scholar 

  26. Schwartz W, Weiss B (1986) Increased incidence of adenocarcinoma of the cervix in young women in the United States. Am J Epidemiol 124:1045

    PubMed  CAS  Google Scholar 

  27. Zheng T, Holford TR, Ma Z et al (1996) The continuing increase in adenocarcinoma of the uterine cervix: a birth cohort phenomenon. Int J Epidemiol 25:252–258

    Article  PubMed  CAS  Google Scholar 

  28. Kjaer SK, Brinton LA (1993) Adenocarcinomas of the uterine cervix: the epidemiology of an increasing problem. Epidemiol Rev 15:486–498

    PubMed  CAS  Google Scholar 

  29. Yoshida T, Fukuda T, Sano T et al (2004) Usefulness of liquid-based cytology specimens for immunocytochemical study of p16 expression and human papillomavirus testing. Cancer Cytopathol 102:100–1008

    CAS  Google Scholar 

  30. Liu S, Semenciw R, Mao Y (2001) Cervical cancer: the increasing incidence of adenocarcinoma and adenosquamous carcinoma in younger women. CMAJ 164(8):1151–1152

    PubMed  CAS  Google Scholar 

  31. Inoue M, Sakaguchi J, Sasagawa T et al (2006) The evaluation of human papillomavirus DNA testing in primary screening for cervical lesions in a large Japanese population. Int J Gynecol Cancer 16:1007–1013

    Article  PubMed  CAS  Google Scholar 

  32. Konno R, Shin HR, Kim YT et al (2008) Human papillomavirus infection and cervical cancer prevention in Japan and Korea. Vaccine 26S:30–42

    Article  Google Scholar 

  33. Schneider-Maunoury S, Croissant O, Orth G (1987) Integration of human papillomavirus type 16 DNA sequences: a possible early event in the progression of genital tumors. J Virol 61:3295–3298

    PubMed  CAS  Google Scholar 

  34. Schwarz E, Fresse UK, Gissmann L et al (1985) Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 314:111–114

    Article  PubMed  CAS  Google Scholar 

  35. Ham J, Dostatni N, Gauthier J et al (1991) The papillomavirus E2 protein: a factor with many talents. TIBS 16:440–444

    PubMed  CAS  Google Scholar 

  36. Choo KB, Pan CC, Han SH (1987) Integration of human papillomavirus type 16 into cellular DNA of cervical carcinoma: preferential deletion of the E2 gene and invariable retention of the long control region and the E6/E7 open reading frames. Virology 161:259–261

    Article  PubMed  CAS  Google Scholar 

  37. Wilczynski SP, Pearlman L, Walker J (1988) Identification of HPV 16 early genes retained in cervical carcinomas. Virology 166:624–627

    Article  PubMed  CAS  Google Scholar 

  38. Badaracco G, Venuti A, Sedati A et al (2002) HPV16 and HPV18 in genital tumors: significantly different levels of viral integration and correlation to tumor invasiveness. J Med Virol 67:574–582

    Article  PubMed  CAS  Google Scholar 

  39. Cullen AP, Reid R, Campion M et al (1991) Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. J Virol 65:606–612

    PubMed  CAS  Google Scholar 

  40. Cheung JLK, Cheung TH, Ng CWY et al (2008) Analysis of HPV 18 viral load and integration status from low-grade cervical lesion to invasive cervical cancer. J Clin Microbiol 47(2):287–293

    Article  PubMed  CAS  Google Scholar 

  41. Park JS, Hwang ES, Park SN et al (1997) Physical status and expression of HPV genes in cervical cancers. Gynecol Oncol 65:121–129

    Article  PubMed  CAS  Google Scholar 

  42. Casas L, Galvan SC, Ordonez RM et al (1999) Asian-American variants of human papillomavirus type 16 have extensive mutations in the E2 gene and are highly amplified in cervical carcinomas. Int J Cancer 83:449–455

    Article  PubMed  CAS  Google Scholar 

  43. Berman J, Casas L, Segura E et al (1994) Genome amplification of human papillomavirus types 16 and 18 in cervical carcinomas is related to the retention of E1/E2 genes. Int J Cancer 56:640–645

    Article  Google Scholar 

  44. Ogura K, Ishi K, Masumoto T et al (2006) Human papillomavirus localization in cervical adenocarcinoma and adenosquamous carcinoma using in situ polymerase chain reaction: review of the literature of human papillomavirus detection in these carcinomas. Pathol Int 56:301–308

    Article  PubMed  CAS  Google Scholar 

  45. Ueda Y, Miyatake T, Okazawa M et al (2008) Clonality and HPV infection analysis of concurrent glandular and squamous lesions and adenosquamous carcinomas of the uterine cervix. Am J Clin Pathol 130:389–400

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest statement

The authors declare that there are no conflicts of interest.

Author information

Authors and Affiliations

  1. School of Health Sciences, Faculty of Medicine, Gunma University, 3-39-15 Showa-machi, Maebashi, Gunma, 371-8511, Japan

    Tomomi Yoshida & Toshio Fukuda

  2. Department of Diagnostic Pathology, Faculty of Medicine, Gunma University Graduate School of Medicine, 3-39-15 Showa-machi, Maebashi, Gunma, 371-8511, Japan

    Takaaki Sano & Tetsunari Oyama

  3. Department of Gynecology and Reproductive Medicine, Faculty of Medicine, Gunma University Graduate School of Medicine, 3-39-15 Showa-machi, Maebashi, Gunma, 371-8511, Japan

    Tatsuya Kanuma

Authors
  1. Tomomi Yoshida
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Takaaki Sano
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tetsunari Oyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Tatsuya Kanuma
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Toshio Fukuda
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tomomi Yoshida.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yoshida, T., Sano, T., Oyama, T. et al. Prevalence, viral load, and physical status of HPV 16 and 18 in cervical adenosquamous carcinoma. Virchows Arch 455, 253–259 (2009). https://doi.org/10.1007/s00428-009-0823-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00428-009-0823-x

Keywords

Search

Navigation